Trafny will co-host a conference focusing on adult stem cell therapies with the pharmaceutical company NeoStem at the Vatican on April 11, a project which the Vatican has partly funded.
This unusual marriage of church and biotech is a targeted public affairs initiative. The Vatican aims to use the partnership to show people there is an alternative to embryonic stem cell research – which it vehemently opposes – that doesn’t involve the destruction of human embryos.
This is great, actually and glad to see this happening.
Science is not scary, folks… not at all